Valeria Pechtner
Neuilly-sur-seine, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Adherence to antihyperglycemic medications and glucagon-like peptide 1-receptor agonists in type 2 diabetes: clinical consequences and strategies for improvement.
Journal: Patient preference and adherence
Published: May 17, 2018
Glucagon-like peptide-1 receptor agonists in type 2 diabetes treatment: are they all the same?
Journal: Diabetes/metabolism research and reviews
Published: December 14, 2017
Clinical inertia and its impact on treatment intensification in people with type 2 diabetes mellitus.
Journal: Diabetes & metabolism
Published: March 22, 2017
Differential effects of once-weekly glucagon-like peptide-1 receptor agonist dulaglutide and metformin on pancreatic β-cell and insulin sensitivity during a standardized test meal in patients with type 2 diabetes.
Journal: Diabetes, obesity & metabolism
Published: January 07, 2016
Early fasting glucose measurements can predict later glycaemic response to once weekly dulaglutide.
Journal: Diabetic medicine : a journal of the British Diabetic Association
Published: June 03, 2015
Treatment satisfaction in people with type 2 diabetes mellitus treated with once-weekly dulaglutide: data from the AWARD-1 and AWARD-3 clinical trials.
Journal: Diabetes, obesity & metabolism
Published: February 19, 2015
Efficacy and Safety of Once-Weekly Dulaglutide Versus Insulin Glargine in Patients With Type 2 Diabetes on Metformin and Glimepiride (AWARD-2).
Journal: Diabetes care
Published: July 02, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026